The effect of injecting drug use history on disease progression and death among HIV‐positive individuals initiating combination antiretroviral therapy: collaborative cohort analysis
Milena Murray(University of British Columbia), C. Tural(Hospital Universitari Germans Trias i Pujol), Colette Smith(MRC Clinical Trials Unit at UCL), Margaret May(James Madison University), Amy C. Justice(Yale University), Ole Kirk(University of Copenhagen), Robert S. Hogg(Simon Fraser University), R I Harris, Pavel Khaykin, Jürgen K. Rockstroh(University of Bonn), M. John Gill(University of Calgary), Rainer Weber(Georg Simon Ohm University of Applied Sciences Nuremberg), Antonella d’Arminio Monforte(University of Milan), Sophie Abgrall(Inserm), DM Moore(University of British Columbia), VD Lima(AIDS Vancouver), Mathias Bruyand(Inserm), Peter Reiss(Amsterdam Institute for Global Health and Development), Michael S Saag(Harborview Medical Center)
Cited by 55
Related Papers
Antiretroviral Treatment of Adult HIV Infection
|JAMA|2012|2.5k
Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies
|The Lancet|2008|1.7k
Industrial enzyme applications
|Current Opinion in Biotechnology|2002|1.5k
Decline in the AIDS and death rates in the EuroSIDA study: an observational study
|The Lancet|2003|1.2k